Evogene Ltd. (EVGN)
NASDAQ: EVGN · IEX Real-Time Price · USD
0.626
-0.031 (-4.79%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Evogene Revenue
In the year 2023, Evogene had annual revenue of $5.64M with 236.72% growth. Revenue in the quarter ending December 31, 2023 was $578.00K, a -12.42% decrease year-over-year.
Revenue (ttm)
$5.64M
Revenue Growth
+236.72%
P/S Ratio
5.61
Revenue / Employee
$39,718
Employees
142
Market Cap
31.62M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
Dec 31, 2019 | 753.00K | -994.00K | -56.90% |
Dec 31, 2018 | 1.75M | -1.63M | -48.33% |
Dec 31, 2017 | 3.38M | -3.16M | -48.30% |
Dec 31, 2016 | 6.54M | -4.59M | -41.23% |
Dec 31, 2015 | 11.13M | -3.38M | -23.31% |
Dec 31, 2014 | 14.51M | -3.07M | -17.46% |
Dec 31, 2013 | 17.58M | 509.00K | 2.98% |
Dec 31, 2012 | 17.07M | 2.17M | 14.57% |
Dec 31, 2011 | 14.90M | 2.34M | 18.61% |
Dec 31, 2010 | 12.56M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Retractable Technologies | 43.60M |
CASI Pharmaceuticals | 33.88M |
Spectral AI | 18.06M |
Palatin Technologies | 7.10M |
Singular Genomics Systems | 2.91M |
Daré Bioscience | 2.81M |
IGC Pharma | 1.22M |
EVGN News
- 11 days ago - Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - PRNewsWire
- 16 days ago - Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting - PRNewsWire
- 25 days ago - Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry - PRNewsWire
- 4 weeks ago - Evogene Announces Filing of Annual Report on Form 20-F - PRNewsWire
- 5 weeks ago - Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - PRNewsWire
- 5 weeks ago - Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing - PRNewsWire
- 6 weeks ago - Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America - PRNewsWire
- 7 weeks ago - Evogene Reports Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire